Anthrax edema factor (EF) raises host intracellular cyclic AMP (cAMP) to pathological levels through a calcium-calmodulin (CaM) dependent adenylyl cyclase activity. Here, we report the structure of EF-CaM in complex with its reaction products, cAMP and 
INTRODUCTION
physiological calcium concentrations (5) . This domain can be further divided into two functional entities. The N-terminal 43 kDa portion of the adenylyl cyclase domain of EF forms the catalytic core which shares 34% and 29% sequence similarity to CyaA and ExoY while the C-terminal 17 kDa helical domain has no catalytic activity but facilitates CaM activation of EF (11) . Structures of the 58 kDa domain of EF alone and in complex with CaM reveals that one of the catalytic loops of EF is disordered in the absence of CaM (6) . CaM has N-and Cterminal globular domains, each binding two Ca 2+ ions (12) . NMR and mutational analyses suggests that the N-terminal CaM initiates its contact with the C-terminal 17 kDa helical domain of EF, which leads to the insertion of C-terminal CaM between the catalytic core and helical domains of EF (5, 13) . The binding of CaM induces the conformational changes to stabilize the disordered catalytic loop, leading to over 1000-fold increase in the catalytic rate (6) .
EF has relatively high catalytic rate with a turnover number around 1-2 ms -1 . With a Km around 0.2-1 mM, the catalytic efficiency (k cat /K m of EF-CaM) approaches 10 7 /M/s, a catalytic rate that is at least 100 fold higher than mammalian adenylyl cyclases (mAC) (5, 6, 14, 15) . Structures of EF3-CaM in complex with several non-cyclizable ATP analogs together with mutational analyses have provided a starting point in building a model of EF catalysis (5, 6, 16) . The adenine moiety is recognized by a main chain carbonyl while the ribose is held in position by an asparagine (N583). The triphosphate moiety is coordinated by several positively charged residues, including Arg 329, Lys 346, Lys 353, and Lys 372. His 351 is near the putative 3'OH. The homologous residue in CyaA (H63) is postulated to act as a catalytic base (17) . This is based on the observation that the mutation of H63 to arginine shifted the pH dependency toward a more alkaline optimum. Thus, H351 is proposed to serve 6 as a catalytic base to generate 3' oxy anion. EF also has two aspartates, Asp 491 and Asp 493 that could coordinate the catalytic metals similar to mAC and many DNA and RNA polymerases (15, (18) (19) (20) (21) (22) (23) (24) .
Little is known about how EF binds and releases reaction products, cAMP and PPi.
Here we report the structure determination of EF-CaM in complex with reaction products, cAMP and PPi as well as a kinetic analysis of EF. These analyses suggest a mechanism for the binding and releasing of reaction products in EF. The structure of EF-CaM in complex with cAMP and PPi also offers evidence suggesting "histidine and two-metal-ion" hybrid mechanism of catalysis. 0.4 mM GTP or cAMP was added as a tracer to monitor the recovery. Phenol extraction was used to separate the nucleotides from the proteins. The aqueous phase was then loaded on reverse-phase C18 HPLC column and eluted with a linear gradient of 0.1 M triethylammonium acetate and acetonitrile.
RESULTS AND DISCUSSIONS
Structure of EF3-CaM in complex with cAMP and PPi: We have determined the structure of the catalytic domain of EF (EF3) and CaM with and without the non-cyclizable ATP analogs (6, 16) . To better understand the catalytic mechanism, we have solved the structure of EF3-CaM in complex with its reaction products, cAMP and PPi. To do so, EF3-CaM crystals were soaked with cAMP and PPi (1 mM each) and the crystal diffracted at best to 3.2Å resolution ( Table 1 ). The structure model of EF and CaM in the EF3-CaM-cAMP-PPi structure is similar to those in EF3-CaM. EF3 consists of the catalytic core (C A and C B ) and helical domains and the extended conformation of CaM inserts in between these two domains of EF3 ( Figure 1A ).
There are three EF-CaM molecules in each asymmetric unit of I222 crystal lattice and the cAMP and PPi molecules are clearly visible in the active site of all three EF molecules based on the simulated annealing omit map contoured at 3.5σ ( Figure 1B ). We have also soaked EF3-CaM crystals with 1 mM cAMP. However, the simulated annealing omit map reveals no visible electronic density of cAMP in the catalytic site of EF, suggesting that PPi is required for the high occupancy of cAMP.
The conformation of cAMP in all three EF3-CaM-cAMP-PPi model of the asymmetry unit is roughly similar. 
Mutational analysis of EF to validate the crucial interactions of EF with its products:
Mutational analysis was used to evaluate whether the EF3-CaM-cAMP-PPi model accurately depicts the interaction of EF with PPi and cAMP. Lys372 forms a salt bridge with 3'dATP (6) , and also appears to make a crucial contact with PPi in the structure of the reaction product.
Thus, we made the EF3-K372A mutant, in which Lys372 is mutated to alanine. This mutation reduced the catalytic rate constant of EF3-K372A 30-fold, and increased the Km value of ATP 3-fold (EF3, 6.0 ms -1 , 0.6 mM; EF3-K372A, 0.2 ms -1 , 2.0 mM) with minimal effect on the EC 50 value for CaM activation (EF3, 12 nM and EF3-K372A, 6 nM). We then tested the ability of cAMP and PPi to inhibit EF3-K372A. Consistent with the structural model, EF3-K372A
had at least a 20-fold increase in the IC 50 value for the inhibition by PPi while its ability to be inhibited by cAMP was not affected (Figure 2A , B).
Lys353 forms a salt bridge with Glu588. This salt bridge forms a "lid" over the catalytic site of EF. In addition, Lys353 is in proximity to form a salt bridge with PPi and phosphate of cAMP. We have previously reported that the mutation of Lys353 to alanine resulted in 500-fold reduction in catalytic rate and 7-fold increase in Km value of ATP without affecting the interaction of EF with CaM (6). Our present kinetic analysis reveals that EF3-K353A also exhibits a 20-fold increase in IC 50 value for the inhibition by PPi. In contrast, the propensity of this mutant to be inhibited by cAMP is unaltered (Figure 2A , B). Lys346 also forms a salt bridge with PPi. The mutation of Lys346 to alanine results in a reduction of catalytic rate greater than four orders of magnitude, making a more accurate kinetic analysis impractical.
In the EF3-CaM-cAMP-PPi structure model, adenosine moiety participates in numerous main chain interactions with EF. Here, the most prominent interaction is the hydrogen bonding of its O'4 atom with Asn583. Our previous analysis showed that the mutation of Asn583 to alanine decreased the catalytic rate constant 150-fold. The same mutation had only a minimal effect on the Km value of ATP or the IC 50 value for CaM activation (6). Consistent with our structural model, EF3-N583A increases the IC 50 value for the inhibition by cAMP about 10-fold, while the sensitivity of this mutant to the inhibition by PPi is the same as that of the wild type enzyme ( Figure 2C , D). Our structures show that Glu588 and Asp590 contribute the organization of the catalytic site of EF (6) but they are not directly involved in the binding of cAMP and PPi. The mutation of these residues to alanine resulted in minimal alteration of the inhibition by cAMP or PPi ( Figure 2C, D) . Thus, our mutational data confirms the structural model of EF3-CaM-cAMP-PPi.
Product inhibition of the EF3-CaM complex:
Patterns of inhibition of enzymatic activity by products can be used to determine whether the release of product is an ordered or random event.
To do so, we examined the inhibition of adenylyl cyclase activity of EF3 by cAMP and PPi , kinetic data could be interpreted as an ordered product release with PPi being released first. This is because the kinetic of inhibition of EF activity by cAMP was competitive while that by PPi was mixed. However, such ordered release became random at 2 µM free Ca 2+ when the kinetics of inhibition of enzymatic activity by either cAMP or PPi were mixed. The kinetic parameters are listed in Table 2 .
This kinetic data is consistent with the structure of EF3-CaM-cAMP-PPi. Upon CaM binding, the catalytic site of EF changes from an open channel to a closed tube that is open at both ends (6) . The EF3-CaM-cAMP-PPi structure reveals that cAMP and PPi have access to different solvent channels, allowing them to exit independently ( Figure 1C . Consequently, PPi has much higher probability to be released first. Although we could not measure the binding affinity of EF-CaM to cAMP or to PPi directly due to their low affinity, we found 7-fold decrease in the IC 50 value for the inhibition by PPi when the free calcium concentration was raised from 0.1 µM to 2 µM ( Figure 3C ). However the same change in the calcium concentration did not alter the IC 50 value for the inhibition by cAMP ( Figure   3C ). This is consistent with the notion that calcium can increase the affinity of PPi for EF.
Kinetic analysis of the reverse reaction of EF-CaM:
The rate of the reverse reaction of EF3, which converts cAMP and PPi to ATP, has been examined by kinetic experiments presented in Figure 4 and Table 2 . We performed an analysis of the rate of ATP synthesis at varying concentrations of cAMP and PPi. An ATP-coupled reaction was used to monitor the ATP concentration. We found that EF3 could readily convert cAMP and PPi to ATP, and that this The nearly 160 o rotation of adenine moiety may represent an important step in the overall reaction mechanism of EF catalysis, which may serve to prevent EF from using GTP as its substrate. While the EF3-3'dATP crystal structure can accommodate equally well anti conformers of both the ATP and GTP substrates, the N2 amino group of syn-GTP would sterically crash into the main chains of EF (Gly578/Thr579), which constitute a part of a loop crucial for catalysis. If this steric clash is indeed important, ITP which lacks the N2 amino
should be a better substrate for EF than GTP. To test this hypothesis, we first examined whether GTP and ITP could serve as the inhibitors for cyclization reaction of EF using ATP as the substrate ( Figure 7A ). We found that GTP acted as a competitive inhibitor of EF with Ki value of 0.3 mM. However, ITP inhibited the reaction of EF with K i value of 3.2 mM in the manner that was mixed inhibition.
We then tested whether ITP and GTP could serve as the substrate for the cyclization reaction of CaM-activated EF. To do so, we performed the cyclization reaction with variable amounts of EF and quantified the production of cyclic nucleotide by HPLC ( Figure 7B ). The resulting catalytic rate from this assay is 250 s -1 , which is similar to the catalytic rate observed in the α- Comparison of the mechanism of catalysis between EF and mAC: From the structural and kinetic analyses, there are at least three major differences in the mechanism of catalysis between EF and mAC models. First is the recognition of adenine moiety. In mAC, the N6 and N1 of adenine forms hydrogen bonds with the side chain of conserved aspartate and lysine, respectively, while only N6 of adenine forms a hydrogen bond with the main chain carbonyl of Thr548 in EF. The additional hydrogen bonding with N1 of adenine in mAC serves to distinguish ATP from GTP. This interaction also prevents a significant rotation of N-glycosyl bond of the substrate. This interpretation is supported by the fact that the interaction of adenine moiety with the mAC model, 5C1-2C2, is nearly identical in the six structures of 5C1-2C2-Gsα in complex with analogs which mimic the substrate and the reaction products (7, 15, 34) .
Another difference between these two classes of adenylyl cyclases is the mechanism of deprotonation of the 3' hydroxyl group. In the mAC model, the deprotonation is attributed to a metal ion only whereas in EF3, both histidine and a metal ion could work in concert. The third difference is the order of product release. Kinetic analysis reveals that cAMP has a high propensity to be released first in mAC. This allows adenosine analogs (P-site inhibitor), which mimic product, to cooperate with PPi to effectively inhibit the catalysis of mAC (14, 34, 35) . In contrast, kinetic data indicate that PPi tends to be released before cAMP in EF. These three differences in the mechanism of catalysis and product release could contribute to the reasons why EF has at least two orders of magnitude higher catalytic activity than mAC (6, 14) .
Conclusion:
From our structural and kinetic analyses, we have revised our model of the mechanism of catalysis in EF. Several hypotheses can be derived from this model that are suitable for evaluation both by computer simulation and empirical studies (32, (36) (37) (38) Better understanding of the catalysis of class II enzymes will advance our understanding of the structural basis of the transition state stabilization by the enzyme environment and, importantly, Supplemental figure 1 The active site of EF3 in complex with cAMP and PPi. 2 Yb 3+ ions is shown with the anomalous difference Fourier map contoured at 6.5σ. Residues in EF3, cAMP, and PPi is colored by their atom color (C atom-grey, N atom-blue, O atom -red, and P atom -yellow).
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